Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mario M. D'Elios is active.

Publication


Featured researches published by Mario M. D'Elios.


Journal of Experimental Medicine | 2003

The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms

Marianna Boncristiano; Silvia Rossi Paccani; Silvia Barone; Cristina Ulivieri; Laura Patrussi; Dag Ilver; Amedeo Amedei; Mario M. D'Elios; John L. Telford; Cosima T. Baldari

Helicobacter pylori toxin, VacA, damages the gastric epithelium by erosion and loosening of tight junctions. Here we report that VacA also interferes with T cell activation by two different mechanisms. Formation of anion-specific channels by VacA prevents calcium influx from the extracellular milieu. The transcription factor NF-AT thus fails to translocate to the nucleus and activate key cytokine genes. A second, channel-independent mechanism involves activation of intracellular signaling through the mitogen-activated protein kinases MKK3/6 and p38 and the Rac-specific nucleotide exchange factor, Vav. As a consequence of aberrant Rac activation, disordered actin polymerization is stimulated. The resulting defects in T cell activation may help H. pylori to prevent an effective immune response leading to chronic colonization of its gastric niche.


The Journal of Allergy and Clinical Immunology | 1997

Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors

Alessandro Lambiase; Luisa Bracci-Laudiero; Sergio Bonini; Stefano Bonini; Giuseppe Starace; Mario M. D'Elios; Marco De Carli; Luigi Aloe

BACKGROUND Increasing evidence shows that nerve growth factor (NGF) plays a role in the complex and fascinating linkage between the nervous and the immune systems due to its ability to modulate functions of several inflammatory cells. OBJECTIVE To investigate NGF receptor expression and NGF production and release by human CD4+ cells clones, which have primary relevance in modulating inflammatory events through their different subsets of functional phenotypes. METHODS The expression of NGF and a transmembrane tyrosine kinase (TrkA) was evaluated by immunohistochemistry and flow cytometry analysis in five T(H0), six T(H1), and five T(H2) cell clones derived from human circulating mononuclear blood cells. Moreover, the amount of NGF protein was assessed by measuring the NGF levels in culture supernatants of the T cell clones before stimulation and 48 hours after phytohemagglutinin (PHA) activation by use of an immunoenzymatic assay. RESULTS Our data have shown that in unstimulated conditions, human CD4+ T cell clones express both immunoreactivity for NGF and the TrkA NGF receptor irrespective of their cytokine profile. Moreover, T(H1) and T(H2) clones, but not T(H0) clones, secrete NGF in basal conditions. PHA activation induces NGF secretion in T(H0) clones and a significant increase of NGF levels in T(H2) (p < 0.05), but not in T(H1) culture supernatants. CONCLUSIONS Results obtained represent the first evidence of TrkA expression and NGF production and release in human CD4+ cell clones and suggest a possible functional role of NGF in modulating the immune and inflammatory network.


European Journal of Immunology | 2001

Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes

Johan Vekemans; Amedeo Amedei; Martin O. C. Ota; Mario M. D'Elios; Tessa Goetghebuer; Jamila Ismaili; Melanie J. Newport; Gianfranco Del Prete; Michel Goldman; Keith P. W. J. McAdam; Arnaud Mayant

The immaturity of the neonatal immune system in mice is associated with defective IFN‐γ production and Th2‐biased immune responses. In this study, infants vaccinated at birth with BCG produced similar concentrations of IFN‐γ in response to PPD and showed similar frequencies of IFN‐γ‐producing lymphocytes as compared to immune adults. Infants and adults produced only low concentrations of IL‐4 and IL‐5. CD4+ T lymphocytes were the main source of IFN‐γ. Similar proportions of Th1 and Th0 PPD‐specific T cell clones were observed in infants and adults. This study demonstrates that the human neonatal immune response to BCG is not biased towards Th2 and is characterized by the predominant production of IFN‐γ by CD4+ T lymphocytes.


Journal of Experimental Medicine | 2003

Molecular Mimicry between Helicobacter pylori Antigens and H+,K+–Adenosine Triphosphatase in Human Gastric Autoimmunity

Amedeo Amedei; Mathijs P. Bergman; Ben J. Appelmelk; Annalisa Azzurri; Marisa Benagiano; Carlo Tamburini; Ruurd van der Zee; John L. Telford; Christina M. J. E. Vandenbroucke-Grauls; Mario M. D'Elios; Gianfranco Del Prete

Autoimmune gastritis and Helicobacter pylori–associated gastric atrophy develop through similar mechanisms involving the proton pump H+,K+–adenosine triphosphatase as autoantigen. Here, we report that H. pylori–infected patients with gastric autoimmunity harbor in vivo–activated gastric CD4+ T cells that recognize both H+,K+–adenosine triphosphatase and H. pylori antigens. We characterized the submolecular specificity of such gastric T cells and identified cross-reactive epitopes from nine H. pylori proteins. Cross-reactive H. pylori peptides induced T cell proliferation and expression of T helper type 1 functions. We suggest that in genetically susceptible individuals, H. pylori infection can activate cross-reactive gastric T cells leading to gastric autoimmunity via molecular mimicry.


European Journal of Immunology | 2002

Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo

Christian Lienhardt; Annalisa Azzurri; Amedeo Amedei; Katherine Fielding; Jackson Sillah; Oumou Sow; Boubacar Bah; Marisa Benagiano; Alimou Diallo; Roberto Manetti; Kebba Manneh; Per Gustafson; Steve Bennett; Mario M. D'Elios; Keith P. W. J. McAdam; Gianfranco Del Prete

Activation of Th1 lymphocytes, IFN‐γ production and macrophage activation are crucial in defense against Mycobacteria. In developing countries, Th2 activation and IL‐4 production have been associated in vitro with tuberculosis and with poor clinical outcome after treatment. Serological markers of Th1 [soluble lymphocyte activation gene (LAG)‐3] and Th2 (IgE, solubleCD30, and CCL22/macrophage‐derived chemokine) activity were measured in 414 HIV‐negative tuberculosis patients from The Gambia and Guinée and in 414 healthy household and community controls. Measurements were repeated during treatment to assess the effect of therapy on Th1/Th2 ratio. At diagnosis, sLAG‐3 levels were lower in patients than in community controls (p<0.0001), but were higher in household controls exposed to contact with patients than in community controls (p<0.0001). In comparison with community controls, patients had consistently higher levels of IgE, sCD30, and CCL22 (p<0.0001), whereas household controls had lower levels of indicators of Th2 activity (p<0.0001). After treatment, cured patients had higher levels of Th1 (p<0.0001) and lower levels of Th2 (p<0.0001) activity than patients who were not successfully treated or interrupted therapy. In Africa, tuberculosis is associated with low Th1 and high Th2 activity in vivo, whereas close exposure to tuberculosis is associated with a high Th1/Th2 ratio. Patients with favorable outcome after treatment exhibit a higher Th1/Th2 ratio compared to patients with poor clinical outcome.


Journal of Experimental Medicine | 2005

Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling

Silvia Rossi Paccani; Fiorella Tonello; Raffaella Ghittoni; Mariarita Natale; Lucia Muraro; Mario M. D'Elios; Wei-Jen Tang; Cesare Montecucco; Cosima T. Baldari

Anthrax is an infection caused by pathogenic strains of Bacillus anthracis, which secretes a three-component toxic complex consisting of protective antigen (PA), edema factor (EF), and lethal factor (LF). PA forms binary complexes with either LF or EF and mediates their entry into host cells. Although the initial phases of bacterial growth occur in the lymph node, the host fails to mount an effective immune response. Here, we show that LT and ET are potent suppressors of human T cell activation and proliferation triggered through the antigen receptor. Both LT and ET inhibit the mitogen-activated protein and stress kinase pathways, and both toxins inhibit activation of NFAT and AP-1, two transcription factors essential for cytokine gene expression. These data identify a novel strategy of immune evasion by B. anthracis, based on both effector subunits of the toxic complex, and targeted to a key cellular component of adaptive immunity.


Proceedings of the National Academy of Sciences of the United States of America | 2003

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

Marisa Benagiano; Annalisa Azzurri; Alessandra Ciervo; Amedeo Amedei; Carlo Tamburini; Mauro Ferrari; John L. Telford; Cosima T. Baldari; Sergio Romagnani; Antonio Cassone; Mario M. D'Elios; Gianfranco Del Prete

Atherosclerotic lesions are infiltrated by macrophages and T lymphocytes, potentially reactive to pathogens. We studied in vivo activated T lymphocytes that infiltrate atherosclerotic plaques of Helicobacter pylori-infected patients with or without anti-Chlamydia pneumoniae antibodies. In all atherosclerotic lesions, T helper type 1 (Th1) cells were predominant. C. pneumoniae-specific T cells were detected only in the plaques of anti-C. pneumoniae seropositive patients, whereas H. pylori-specific T cells were found in the gastric mucosa but not in the plaques of the same patients. Plaque-derived Th1 cells expressed cytotoxicity, proapoptotic activity, and help for monocyte tissue factor production. Although multifactorial, atherosclerosis can be regarded as a Th1-driven immunopathological condition.


Journal of Leukocyte Biology | 1997

In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells.

Mario M. D'Elios; Paola Romagnani; Cristina Scaletti; Francesco Annunziato; M. Manghetti; Carmelo Mavilia; Paola Parronchi; Cinzia Pupilli; Giovanni Pizzolo; Enrico Maggi; G Del Prete; Sergio Romagnani

CD3O is a member of the tumor necrosis factor (TNF) receptor family, originally described as a marker for Hodgkin and Reed‐Sternberg cells in Hodgkins disease, which has been found to be preferentially expressed by T cells producing Th2‐type cytokines. The presence of CD3O expression was assessed by both immunohistochemistry and reverse transcriptase‐polymerase chain reaction in the target organs of patients with Th1‐ or Th2‐dominated disorders. CD3O expression was found in neither the gut of patients with Crohns disease nor in the gastric antrum of Helicobacter pylori‐infected patients, where there was high interferon‐γ (IFN‐γ) expression. In contrast, high CD3O expression in the apparent absence of IFN‐γ expression was observed in the skin of patients with systemic sclerosis or chronic graft versus host disease (GVHD), which can be considered Th2‐dominated disorders. Moreover, high levels of soluble CD3O were found in the serum of both systemic sclerosis and GVHD patients but not in the serum of patients suffering from multiple sclerosis, a Th1‐dominated disorder. Thus, CD3O expression appears to be preferentially associated with Th2‐type responses not only in vitro but also in vivo. J. Leukoc. Biol. 61: 539–544; 1997.


Autoimmunity | 1994

Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity.

Marco De Carli; Mario M. D'Elios; Gianna Zancuoghi; Sergio Romagnani; Gianfranco Del Prete

Evidence has accumulated suggesting the existence in humans of polarized T helper (Th) cell subsets, coded as Th1 and Th2, with defined cytokine secretion profiles. Immune responses to intracellular bacteria and viruses result in the preferential development of the Th1 cell subset. Th1 cells express cytolytic activity against antigen-presenting cells and provide helper function for IgM, IgG and IgA synthesis only at low T/B cell ratios. In contrast, Th2 cells develop in response to allergens or helminth antigens, provide help for all immunoglobulin classes, including IgE, and lack cytolytic potential. The cytokine milieu in the microenvironment plays a fundamental role in determining the functional phenotype of the subsequent antigen-specific Th1 or Th2 responses. In recent years it has become clear that Th1 and Th2 cells play different roles not only in protection against exogenous offending agents, but also immunopathology. Th2 cells are involved in immunopathology induced by helminths and are responsible for the initiation and maintenance of allergic disorders. Th1 cells seem to be involved in contact dermatitis, acute allograft rejection and organ-specific autoimmunity, such as thyroid autoimmune disorders, diabetes mellitus or multiple sclerosis, whereas less polarized patterns of Th cells are detectable in target organs of patients with rheumatoid arthritis. Sjogrens syndrome or systemic lupus erythematosus.


Arthritis & Rheumatism | 2008

Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis.

Gaia Codolo; Amedeo Amedei; Allen C. Steere; Elena Papinutto; Andrea Cappon; Alessandra Polenghi; Marisa Benagiano; Silvia Rossi Paccani; Vittorio Sambri; Gianfranco Del Prete; Cosima T. Baldari; Giuseppe Zanotti; Cesare Montecucco; Mario M. D'Elios; Marina de Bernard

OBJECTIVE Human Lyme arthritis caused by Borrelia burgdorferi is characterized by an inflammatory infiltrate that consists mainly of neutrophils and T cells. This study was undertaken to evaluate the role of the innate and acquired immune responses elicited by the neutrophil-activating protein A (NapA) of B burgdorferi in patients with Lyme arthritis. METHODS Serum anti-NapA antibodies were measured in 27 patients with Lyme arthritis and 30 healthy control subjects. The cytokine profile of synovial fluid T cells specific for NapA was investigated in 5 patients with Lyme arthritis. The cytokine profile induced by NapA in neutrophils and monocytes was also investigated. RESULTS Serum anti-NapA antibodies were found in 48% of the patients with Lyme arthritis but were undetectable in the healthy controls. T cells from the synovial fluid of patients with Lyme arthritis produced interleukin-17 (IL-17) in response to NapA. Moreover, NapA was able to induce the expression of IL-23 in neutrophils and monocytes, as well as the expression of IL-6, IL-1beta, and transforming growth factor beta (TGFbeta) in monocytes, via Toll-like receptor 2. CONCLUSION These findings indicate that NapA of B burgdorferi is able to drive the expression of IL-6, IL-1beta, IL-23, and TGFbeta by cells of the innate immune system and to elicit a synovial fluid Th17 cell response that might play a crucial role in the pathogenesis of Lyme arthritis.

Collaboration


Dive into the Mario M. D'Elios's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G Del Prete

University of Florence

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge